Professor of Biochemistry and Wellcome Principal Research Fellow, University of Dundee, UK
Professor Alan Fairlamb, a Wellcome Principal Research Fellow from 1996–2016, works in the Division of Biological Chemistry & Drug Discovery, University of Dundee. He was educated in Medicine (MB ChB, 1971) and Biochemistry (PhD, 1975) at the University of Edinburgh (UK).
Alan has published over 280 articles and reviews on parasitic diseases covering topics such as: modes of drug action; mechanisms of drug resistance; metabolic pathways; chemical and genetic validation of novel drug targets; and drug discovery.
A tireless advocate of the urgent need for new drugs for neglected diseases of poverty, over the past 30 years Alan has served as a scientific advisor to WHO/TDR, Wellcome Trust, Burroughs Wellcome Fund, MRC, BBSRC, MMV and DNDi. Currently he is a Trustee for the Tres Cantos Open Lab Foundation.
In 2006, he co-founded the Drug Discovery Unit at Dundee that has delivered pre-clinical candidates for sleeping sickness, visceral leishmaniasis and malaria.